pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›angiotensin II
drug · protein
save

angiotensin II

Phase 1updated 3mo ago
by Platform Therapeutics Inc🔗 ChEMBL
Phase 1
community read0 votes

🐶 often sniffed alongside

top 1
  • companyEmory University1 co-mentions · 1 sources

Protein drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 6 investigational indications.

targets

Type-1 angiotensin II receptor

all catalysts(0)

nothing on the calendar yet

Trials studying angiotensin II

  • phase4Angiotensin II for Distributive Shockterminatedn=2
  • phase2Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)recruitingn=15
  • phase3Angiotensin II in Liver Transplantationactive not recruitingn=50
  • phase4Serum Biomarkers to Predict Response to Angiotensin II in Septic Shockcompletedn=40
  • phase4ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)recruitingn=100
  • phase3Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shockrecruitingn=214
  • phase4Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shockrecruitingn=50
  • phase4Angiotensin II vs. Vasopressin in Septic Shockwithdrawn
more trials →

News(0)

no news has mentioned this drug yet

generic
angiotensin II
MOA
Type-1 angiotensin II receptor agonist
indication
Muscle Spasm
phase
phase_1
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 23m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?